Clinical Trials Sponsored by Sandefjord kommune

Total 331 results

Oslo University Hospital
Norwegian Centre for Ageing and Health; The Hospital of Vestfold; Sandefjord...

Completed

Delirium in Home-dwelling Old People Receiving Home Nursing Care

Delirium

Norway
University of Copenhagen
Københavns Kommune; Aarhus Kommune; Hvidovre Kommune; Horsholm Municipality; Samarbejde... and other collaborators

Recruiting

SES Children (SES Mini/SES Nxt) - A Digital Intervention for Children of Divorce (SES Children)

Parental Divorce | Parental Relationship Dissolution | Mental Health and Well-being

Denmark
University of Copenhagen
Sygekassernes Helsefond; Københavns Kommune; The Danish Dental Association; Postgraduate... and other collaborators

Active, not recruiting

Sleep, Upper Airway and Dental Occlusion in Children With Large Overjet

Overjet, Dental

Denmark
Region Örebro County
Örebro kommun; Kumla kommun

Withdrawn

Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years? (U-PROTECT)

Urinary Incontinence | Urinary Tract Infections | Cognition Disorders in Old Age | Incontinence-associated Dermatitis | Behavioral and Psychiatric Symptoms of Dementia

Sweden
CoImmune

Terminated

Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

United States
Parker Research Institute
Oak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaborators

Recruiting

Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial) (Go:OT)

Chronic Disease | Chronic Conditions, Multiple | Chronic Condition

Denmark
Parker Research Institute
Oak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaborators

Active, not recruiting

Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT)

Chronic Conditions, Multiple | Chronic Condition

Denmark
Københavns Kommune
Copenhagen University Hospital, Hvidovre

Completed

Exercise for People With Peripheral Neuropathy and Diabetic Foot Ulcers - a Case Series on Feasibility and Safety

Diabetes Mellitus | Foot Ulcer

Denmark
NImmune Biopharma

Terminated

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

Crohn's Disease

United States
NImmune Biopharma

Completed

Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers

Normal Healthy Volunteers

Australia
NImmune Biopharma

Withdrawn

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

Crohn's Disease
NImmune Biopharma

Completed

Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

Ulcerative Colitis

United States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
NImmune Biopharma

Withdrawn

Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis

Eosinophilic Esophagitis
NImmune Biopharma

Completed

Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers

Normal Healthy Volunteers

United States
Aummune Ltd.

Recruiting

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Solid Tumor

Israel
Evommune, Inc.

Completed

Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

Atopic Dermatitis Eczema

United States
Norwegian University of Science and Technology
Trondheim Kommune

Active, not recruiting

Activity and Health in Nursing Homes

Frailty | Old Age

Norway
Norwegian University of Science and Technology
Trondheim Kommune

Completed

Effect of a Health Promotion Intervention for People With Chronic Pain at a Healthy Life Centre

Chronic Pain

Norway
Aimmune Therapeutics, Inc.

Completed

Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

Peanut Allergy

United States, Canada, Spain, Netherlands, Germany, United Kingdom, Ireland, Sweden, France, Italy
Aimmune Therapeutics, Inc.

Terminated

Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy

Hen Egg Allergy

United States
Aimmune Therapeutics, Inc.

Completed

Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) (RAMSES)

Peanut Allergy

United States, Canada
Aimmune Therapeutics, Inc.

Terminated

Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents

Peanut Allergy

Spain
Timmune Biotech Inc.

Unknown

Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy

Non-hodgkin Lymphoma,B Cell

China
Immune Design

Terminated

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Melanoma | Sarcoma | Ovarian Cancer | Non-small Cell Lung Cancer

United States
Immune Pharmaceuticals

Unknown

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

Ulcerative Colitis, Active Severe | Ulcerative Colitis, Active Moderate

Israel
Immune Control

Unknown

Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Multiple Myeloma

United States
Norwegian University of Science and Technology
Trondheim Kommune

Completed

Improvement After Physiotherapy for Low Back Pain: The Good Responders

Low Back Pain

Norway
University of Southern Denmark
Vejle Hospital; Vejle Kommune

Completed

The GP's Role in Cancer Rehabilitation: a Randomised, Controlled Study.

HRQOL (Health Related Quality Of Life)

Denmark
Aimmune Therapeutics, Inc.

Completed

Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT (ARC001)

Peanut Allergy

United States
Aimmune Therapeutics, Inc.

Completed

Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study

Peanut Allergy

United States
Aimmune Therapeutics, Inc.

Completed

AR101 Real-World Open-Label Extension Study

Peanut Allergy

United States, Canada
Aimmune Therapeutics, Inc.

Completed

ARTEMIS Peanut Allergy In Children (ARTEMIS)

Peanut Allergy

United Kingdom, Italy, France, Germany, Ireland, Spain, Sweden
Timmune Biotech Inc.

Unknown

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Non-Hodgkin Lymphoma

China
Immune Design

Terminated

A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)

Sarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic Sarcoma

United States, Canada
Immune Design

Completed

A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma

Merkel Cell Carcinoma

United States
Immune Pharmaceuticals

Completed

Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

Pemphigoid, Bullous

United States, Israel
Immune Design

Completed

A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer

Melanoma | Sarcoma | Breast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer

United States
University of Aarhus
Randers Municipality, Denmark; Aarhus Kommune

Completed

Childhood Obesity, Lifestyle Interventions and Weight Development

Pediatric Obesity

Denmark
Hvidovre University Hospital
University of Copenhagen; Københavns Kommune

Completed

The Effect of Protein and Resistance Training on Muscle Mass in Acutely Ill Old Medical Patients

Systemic Inflammatory Response Syndrome

Denmark
Aimmune Therapeutics, Inc.

Completed

Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)

Peanut Allergy

United States, United Kingdom, France, Germany
Aimmune Therapeutics, Inc.

Completed

Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) (PALISADE)

Peanut Allergy

United States, Spain, Ireland, Netherlands, Canada, United Kingdom, Germany, Denmark, Italy, Sweden
Aimmune Therapeutics, Inc.

Completed

PALISADE Follow-on Study (ARC004)

Peanut Allergy

United States, Spain, Netherlands, Italy, Canada, Germany, Ireland, Sweden, United Kingdom
Smart Immune SAS

Recruiting

Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors (SMART101-HV1)

Healthy Volunteers

France
Immune Biosolutions Inc

Completed

Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19

COVID-19

South Africa, Ukraine
Repertoire Immune Medicines

Terminated

RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Melanoma | Cervical Cancer | Head and Neck Squamous Cell Carcinoma

United States
Repertoire Immune Medicines

Terminated

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Melanoma | Head and Neck Cancer | HPV-Related Malignancy | Melanoma (Skin) | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Lung Cancer, Nonsmall Cell

United States
AC Immune SA

Withdrawn

A Study of ACI-24 in Adults With Down Syndrome

Down Syndrome
Intervene Immune, Inc.

Recruiting

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X)

Immunosenescence | Epigenetic Aging

United States
Immune-Onc Therapeutics

Active, not recruiting

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Solid Tumor, Adult

United States
Immune Biosolutions Inc

Completed

Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness

COVID-19

South Africa, Brazil

Clinical Trials Sponsored by Sandefjord kommune

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations